Entrada Therapeutics
TRDA
#7397
Rank
A$0.51 B
Marketcap
$13.82
Share price
-1.34%
Change (1 day)
-27.08%
Change (1 year)

P/S ratio for Entrada Therapeutics (TRDA)

P/S ratio as of April 2025 (TTM): 1.57

According to Entrada Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.7709. At the end of 2024 the company had a P/S ratio of 3.09.

P/S ratio history for Entrada Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.09-20.81%
20233.90
2022N/A
2021N/A